Identification of key genes and validation of key gene aquaporin 1 on Wilms’ tumor metastasis
- Published
- Accepted
- Received
- Academic Editor
- Srinivas Sistla
- Subject Areas
- Bioinformatics, Cell Biology, Molecular Biology, Pediatrics, Medical Genetics
- Keywords
- Wilms’ tumor, Aquaporin1, Suppressor gene, Metastasis, Cytoskeleton
- Copyright
- © 2023 Liu et al.
- Licence
- This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.
- Cite this article
- 2023. Identification of key genes and validation of key gene aquaporin 1 on Wilms’ tumor metastasis. PeerJ 11:e16025 https://doi.org/10.7717/peerj.16025
Abstract
Background
Wilms’ tumor (WT) is one of the most common solid tumors in children with unsatisfactory prognosis, but few molecular prognostic markers have been discovered for it. Many genes are associated with the occurrence and prognosis of WT. This study aimed to explore the key genes and potential molecular mechanisms through bioinformatics and to verify the effects of aquaporin 1 (AQP1) on WT metastasis.
Methods
Differentially expressed genes (DEGs) were generated from WT gene expression data sets from the Gene Expression Omnibus (GEO) database. Gene functional enrichment analysis was carried out with the Database for Annotation, Visualization and Integrated Discovery (DAVID). A protein–protein interaction network (PPI) was constructed and visualized by the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database and Cytoscape software. Minimal Common Oncology Data Elements (MCODE) was used to detect the important modules in the PPI network, and the important nodes (genes) in the PPI module were sorted by CytoHubba. RT-qPCR was performed to validate the expression of the key genes in WT. Wound healing and Transwell assays were used to detect the cell migration and invasion abilities of AQP1-overexpressing cells. Phalloidin-iFlour 488 was used to stain the cytoskeleton to observe how AQP1 overexpression affects cytoskeletal microfilament structure.
Results
A total of 73 co-expressed DEGs were chosen for further investigation. The importance of homeostasis and transmembrane transport of ions and water were highlighted by functional analysis. Gene regulatory network and PPI network were predicted. MCODE plug identified two important modules. Finally, top five key genes were identified using CytoHubba, including Renin (REN), nephrosis 2 (NPHS2), Solute Carrier Family 12 Member 3 (SLC12A3), Solute Carrier Family 12 Member 1 (SLC12A1) and AQP1. The five key genes were mainly enriched in cell volume and ion homeostasis. RT-qPCR confirmed the expression of the five key genes in WT. AQP1 was validated to be expressed at significantly lower levels in WT than in normal tissue. AQP1 overexpression significantly reduced the migratory and invasive capacity of Wit-49 cells, as evidenced by reducing the scratch healing rate and the number of perforated control cells by Wit-49 cells. AQP1 overexpression also reduced the expression of biomarkers of epithelial-mesenchymal transformation, decreased levels of vimentin and N-cadherin and increased expression of E-cadherin, resulting in decreased formation of conspicuous lamellipodial protrusions, characteristic of diminished WT cell invasion and migration.
Conclusion
Our study reveals the key genes of WT. These key genes may provide novel insight for the mechanism and diagnosis of WT. AQP1 overexpression inhibited invasion, migration, EMT, and cytoskeletal rearrangement of WT cells, indicating that AQP1 plays a role in the pathogenesis of WT.
Introduction
Wilms’ tumor (WT) is the predominant malignant renal neoplasm in childhood, comprising around 90% of pediatric kidney neoplasms (Breslow et al., 1993). Early-stage WT typically presents with subtle or no discernible symptoms, which brings great difficulties to the early diagnosis of the disease. Despite significant advancements in the treatment of WT over the past few decades, there is still a pressing need to improve the survival rate of patients. Although much progress has been made in WT treatment in recent decades, the survival rate for patients with WT still needs to be improved: 2.2% of patients relapse after first-line therapy and up to 25% of survivors report severe late morbidity of treatment (Suh et al., 2020; Termuhlen et al., 2011). Novel biomarkers, therefore, are urgently needed in order to diagnose the disease early and develop novel target-specific therapies. However, the integration of factors such as genotype, biomarkers, and other risk assessment parameters in WT lags behind compared to other pediatric malignancies. It is very important to improve the prognosis for WT patients by promoting the treatment based on clinical and biological risk factors, and further stratification of current treatment options based on tumor biology (Treger et al., 2019; Zhou et al., 2021).
In early research on WT, susceptibility loci were identified through genetic linkage studies in familial cases, including 11p13 (WT1), 17q21 (FWT1), 19q13.13 (FWT2), and 11p15 (Call et al., 1990; Karnik et al., 1998; Rahman et al., 1996). With the development of modern genetic technology, BCOR, MAP3K4, BRD7, CREBBP and HDAC4 were involved in histone modifications during kidney formation, and they were verified to have genetic mutations in WT (Gadd et al., 2017). Recently, additional putative susceptibility genes, including REST, CHEK2, EP300, PALB2, and ARID1A, have been discovered in WT (Gadd et al., 2017; Mahamdallie et al., 2015). Nonetheless, the precise biological mechanisms responsible for the roles of these genes in WT are still not fully elucidated. Clear molecular mechanisms are yet to be established. Investigating the key genes associated with WT development will contribute to a deeper understanding of biological mechanisms, early diagnosis, and prognostic implications for WT.
With the progress of molecular biology and computer science and technology, bioinformatics has developed rapidly, leading to the emergence of genomic concepts such as those revealed by genomic, transcriptomic, proteomic, and metabolic analyses. GEO (Gene Expression Omnibus) serves as a comprehensive oncology database, encompassing vast sequencing and clinical data pertaining to diverse tumor types. In contemporary research, the analysis of data matrices using bioinformatics has become a prevalent approach for identifying genes with differentially expressed genes (DEGs) and performing diverse analytical investigations. The integration of multiple databases enables the amalgamation of data from independent studies, thereby augmenting the sample size for analysis and enhancing the robustness and precision of the findings. Based on the aforementioned considerations, we collated patient data afflicted with Wilms tumor (WT) from the GEO database to facilitate further analysis using bioinformatics tools and experimental validations.
In this study, bioinformatics analysis was used to explore the key genes and the underlying molecular mechanisms of WT. Also, we wanted to conduct preliminary validation of the expression levels and functional mechanisms of key genes in WT.
Materials and Methods
Materials
The gene expression profile data sets with accession numbers GSE57269, GSE73209 and GSE66405 were found from the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/) (Edgar, Domrachev & Lash, 2002). Previously, Shukrun et al. (2014) submitted chip data (GEO accession GSE57269) to Platform GPL15207, Karlsson et al. (2016) submitted chip data (GEO accession GSE73209) to Platform GPL10558, and Ludwig et al. (2016) submitted chip data (GEO accession GSE66405) to Platform GPL17077. The GSE57269 data set contains 7 Wilms’ tumor samples (Registration number: GSM1378119∼GSM1378125) and 1 normal kidney sample (Registration number: GSM1378118). The GSE73209 data set contains 32 Wilms’ tumor samples (Registration number: GSM1888569∼GSM1888600) and 6 normal kidney samples (Registration number: GSM1888603∼GSM1888608). The GSE66405 data set contains 28 Wilms’ tumor samples (Registration number: GSM1621548∼GSM1621575) and 4 normal kidney samples (Registration number: GSM1621576∼GSM1621579).
Methods
DEG identification
To identify differentially expressed genes (DEGs) in Wilms’ tumor (WT), the online tool GEO2R (http://www.ncbi.nlm.nih.gov/geo/geo2r/) from the Gene Expression Omnibus (GEO) database was utilized. GEO2R enables the comparison of multiple sample groups within a GEO series (Barrett et al., 2013). In this study, the DEGs were screened using GEO2R from three WT sample gene chip datasets: GSE57269, GSE73209, and GSE66405. To reduce false positives, the p values were adjusted using the Benjamini–Hochberg method to control the false discovery rate (FDR). The selection criteria for DEGs included a threshold of —log2fold-change (FC)— ≥1.5 and adjusted p value < 0.05. DEGs between WT samples and normal samples were identified by comprehensive analysis. The online tools were used to draw the volcano map of DEGs in two data sets. Venn diagrams (Pirooznia, Nagarajan & Deng, 2007) of co-expressed DEGs were drawn by online tools.
GO and KEGG pathway enrichment analysis
Enrichment analysis is a commonly used method to analyze gene sets derived from genomic studies and identify their associated biological functions and signaling pathways. For the analysis of gene function and pathway enrichment, we utilized the Database for Annotation, Visualization, and Integrated Discovery (DAVID), (https://david.ncifcrf.gov), a comprehensive web-based resource (Huang da, Sherman & Lempicki, 2009). This resource facilitated Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses in our study. Significance was determined based on an adjusted p value threshold of < 0.05.
PPI network and key genes were selected
The protein–protein interaction network (PPI) was investigated using the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database (https://string-db.org/) (Szklarczyk et al., 2019). The DEGs were subjected to analysis in STRING, leading to the construction of the PPI network. To ensure reliability, a minimum interaction score of 0.7, denoting high confidence, was employed as the cutoff threshold. In the PPI network, high confidence score was used as indicators to filter and determine the reliability and repeatability of protein interactions. Setting 0.7 as the minimum value was done to ensure that the resulting PPI network has a higher level of confidence and biological significance. The PPI network was visualized using Cytoscape v3.7.2 software (https://cytoscape.org/) (Shannon et al., 2003). To identify significant modules within the network, we utilized the Molecular Complex Detection (MCODE) plugin, a tool integrated with Cytoscape. The module identification process involved applying specific criteria, including a degree cutoff of 2, a node score cutoff of 0.2, a K-core value of 2, and a maximum depth of 100 (Bader & Hogue, 2003). By applying the aforementioned criteria, it is possible to filter and identify modules that exhibit high connectivity, dense interactions, and biological relevance, enabling a better understanding of protein interactions and biological functions. We employed the CytoHubba plugin in Cytoscape (Chin et al., 2014) to rank and explore crucial genes within the PPI network modules. For the top 5 key genes, we conducted enrichment analyses using DAVID, applying a significance criterion of an adjusted p value < 0.05, for both GO and KEGG enrichment analyses.
Gene regulatory network analysis
We utilized the eXpression2Kinases (X2K) web-based application (Clarke et al., 2018) (https://amp.pharm.mssm.edu/X2K/) to examine the participation of upstream cellular signaling pathways and establish the regulatory connections among transcription factors (TFs), protein kinases, and their target genes. By employing default parameters, X2K was utilized to examine the upstream regulatory network governing the gene expression regulation of the upregulated genes. The inferred network, which consisted of co-expressed differentially expressed genes, was constructed and visualized.
Cell culture and tissues
WT Wit-49 cells and human renal tubular epithelial cells (HK-2) were obtained from the Cell Bank of the Chinese Academy of Sciences. These cells were cultured in a medium supplemented with 10% fetal bovine serum (FBS) under standard conditions: 37 °C and 5% CO2. From May 2013 to May 2021, WT and matched normal renal tissues from 32 children with pathologically confirmed WT were collected from the Affiliated Hospital of Qingdao University. None of these patients had received adjuvant radiotherapy or chemotherapy prior to surgical intervention. This study was conducted in accordance with the ethical guidelines set by the Ethics Committee of the Affiliated Hospital of Qingdao University (Registration No. QYFY WZLL 27451). Prior written informed consent was obtained from the parents or legal guardians of all the participating children.
RNA extraction and quantitative real-time PCR (qRT–PCR) analysis
Total RNA from the gastrocnemius was extracted using TRIzol reagent (Invitrogen, Grand Island, NY, USA), and reverse transcription of RNA into complementary DNA (cDNA) was performed using a reverse transcription kit (TaKaRa, Shiga, Japan) and oligo (dT) primers. qRT–PCR (Ying et al., 2017) was conducted using gene-specific primers and SYBR Green qPCR mix (Thermo Fisher, Waltham, MA, USA). The primer pairs were as follows: Renin forward: 5′-CTCTACACTGCCTGTGTGTATC-3′, Renin reverse: 5′-CACTGACTGTCCCTGTTGAATA-3′. NPHS2 forward: 5′-CTGTGAGTGGCTTC-TTGTCCTC-3′, NPHS2 reverse: 5′-CCTTTG GCTCTTCCAGGAAGCA-3′. SLC12A3 forward: 5′-TGGACGACCATTTC CTACCTGG-3′, SLC12A3 reverse: 5′-CACTCGGTGAAG TTCCAGCCAT-3′. SLC12A1 forward: 5′-AGGCTCTTTCCTACGTGAGTGC-3′, SLC12A1 reverse: 5′-GCCACTGTTCTTGGTAAAGGCG-3′. AQP1 forward: 5′-CTGTGGGATTAA CCCTGCTCG-3′, AQP1 reverse: 5′-GAAG -CTCCTGGAGTTGATGTCG-3′. GAPDH was used as a reference for each sample.
Western blotting
Western blotting (WB) was conducted following a previously described protocol (Barik et al., 2014). Total protein was extracted using RIPA Lysis Buffer (Beyotime, China), and the protein concentration was determined using the Bicinchoninic Acid (BCA) Protein Assay (Beyotime, China). SDS-PAGE was performed to separate the protein samples, which were then transferred to a nitrocellulose membrane, blocked, and probed with primary antibodies, including anti-AQP1, anti-Vimentin (1:1000; Abcam, Cambridge, UK), E-Cadherin (1:1000; CST, USA), N-Cadherin (1:1000; CST, USA), and anti-β-actin (1:1000; Abcam, Cambridge, UK). The membranes were subsequently incubated with horseradish peroxidase (HRP)-conjugated secondary antibodies (1:1000; Invitrogen, Waltham, MA, USA). Immunoreactive protein bands were visualized using an HRP chemiluminescence detection reagent (ECL; Thermo Fisher Scientific), and the blots were imaged using a ChemiDoc MP imaging system (Bio-Rad, Hercules, CA, USA). The grayscale values were quantified by ImageJ.
Immunohistochemical (IHC) staining
Paraffin sections of WT and matched normal kidney tissues (more than five cm from the edge of the cancer focus) were stained with an anti-AQP1 antibody. Before staining, the paraffin-embedded tissue sample was cut into 4 µm sections, dewaxed, rinsed in anhydrous xylene, and rehydrated by gradient ethanol for antigen repair (Al-Dhohorah et al., 2016). To block endogenous peroxidase activity, the sliced samples were exposed to 3% hydrogen peroxide, followed by three washes with phosphate-buffered saline (PBS). Subsequently, the samples were sealed with a 5% FBS-PBS solution for 15 min and then incubated overnight at 4 °C with the primary antibody. On the following day, the samples were incubated with the secondary antibody for 60 min. Finally, 3,3′-diaminobenzidine (DAB) was detected by immunohistochemical Avidin-Biotin Complex (ABC) staining. Under a light microscope, the cytoplasm or nucleus was stained yellow or brown for positive staining, and samples without staining were negative. The images were taken at 100 × and 200 × magnification. ImageJ software was used to analyze the optical density of the immunohistochemical photos. Three pathological sections of each specimen were taken to detect the cumulative integrated optical density (IOD), and the average value was calculated.
Transfection
Wit-49 cells were maintained in a 37 °C incubator with 5% CO2 until they reached approximately 70% confluence. The AQP1 cDNA (NM_198098) plasmid or a negative control plasmid was obtained from GeneChem (Shanghai, China) and transfected into Wit-49 cells using Lipofectamine 3000 (Invitrogen, CA, USA). After 24 h of incubation, the medium was replaced, and the corresponding functional assays were performed 24 h later. Protein extraction was conducted 48 h after transfection, and the overexpression of AQP1 was confirmed by Western blotting.
Wound healing to detect cell migration
Confluent monolayers of AQP1-overexpressing cells and negative control cells were subjected to a defined wound by manually removing a 300–500 µm strip of cells using a standard 200 µl pipette tip. The wounded monolayers were washed twice to eliminate nonadherent cells. The speed of wound healing was quantified by measuring the average linear migration rate of the wound edges over a 24-hour period. Cell migration was observed under a light microscope, and cell mobility was calculated using ImageJ analysis software as follows: Cell mobility = (0 h scratch area-24 h scratch area)/0 h scratch area. The average was calculated from 3 independent experiments.
Transwell assays to detect cell invasion
For the analysis of invasion ability, chambers coated with Matrigel (Corning, NY, USA, 354480) were utilized to culture AQP1-overexpressing cells and negative control cells. After incubating for 24 h, the cells that migrated through the Transwell chambers were fixed using methanol and stained with Giemsa. The number of migrated cells was quantified by examining five randomly chosen fields per well under a microscope. The average value was calculated based on data obtained from three independent experiments.
Phalloidin-iFlour 488 staining of the cytoskeleton
Cells were seeded onto cell climbing tablets and cultured for 24 h. After that, they were fixed using 4% paraformaldehyde for 20 min. To enhance cell permeability, a 0.1% Triton X-100 solution was applied for 15 min. For fluorescence staining of F-actin, coverslips were treated with Phalloidin-iFlour 488 reagent (ab176753) (1:1000; Abcam, Cambridge, UK) at room temperature for 45 min, while being protected from light. After washing the cells three times with PBS, nuclear staining was performed using DAPI in the fluorescence assay. Finally, all cells were observed using a Laser Scanning Confocal Microscope (LSCM) (Nikon, Tokyo, Japan) following mounting. Phalloidin-iFlour 488 staining of F-actin revealed the cytoskeleton, which appeared as green fluorescence, and DAPI staining was used to stain the nuclei. Then, we overlapped the two parts.
Statistical analysis
The mean and standard deviation (SD) were used to present the data. Statistical analysis was performed using SPSS version 22.0 software (SPSS, Chicago, IL, USA). T tests were conducted for statistical evaluation, and a p value < 0.05 was considered indicative of significant differences.
Results
Identification of WT-related genes
The research flowchart of this study is shown in Fig. 1. GSE57269 contains 7 WT samples and 1 normal kidney sample, GSE73209 contains 32 WT samples and 6 normal kidney samples, and GSE66405 contains 28 WT samples and 4 normal kidney samples. A total of 5128 DEGs in WT were screened, including 1284 upregulated genes and 3844 downregulated genes (—log2fold-change (FC)— ≥1.5 and adjusted p value < 0.05) (Figs. 2A, 2B, 2C). The intersection of the three groups of DEGs contained 73 genes (co-expressed DEGs) (Fig. 2D).
GO and KEGG pathway enrichment analysis of the co-expressed DEGs
In order to gain a deeper understanding of the co-expressed DEGs, we conducted enrichment analyses for GO and KEGG pathways. The GO enrichment analysis included categories such as biological process (BP), cell component (CC), and molecular function (MF). The results revealed that the co-expressed DEGs were primarily associated with BP terms such as “sodium ion homeostasis”, “sodium ion transmembrane transport”, and “multicellular organismal water homeostasis.” In terms of CC, they were enriched in terms such as “extracellular exosome” and “apical plasma membrane”. As for MF, the DEGs were mainly involved in “protein binding” and “sodium: potassium: chloride symporter activity” (Fig. 3A). KEGG pathway analysis identified significant enrichment of the co-expressed DEGs in processes such as “Metabolic pathways”, “Proximal tubule bicarbonate reclamation”, and ”Aldosterone-regulated sodium reabsorption” (Fig. 3B). Taken together, these findings highlight that the co-expressed DEGs may be associated with homeostatic and transmembrane transport of intracellular water and ions, mainly involved in metabolism-related signaling pathway.
Key genes were selected by the PPI network
The STRING database was applied to construct a protein-protein interaction (PPI) network comprising 73 co-expressed DEGs to explore core modules and key genes, both of which could play a central role in the network. The PPI network, including 48 nodes (genes) and 93 edges (interactions), was further analyzed by two built-in algorithms within Cytoscape (Fig. 4A). MCODE identified highly interconnected protein subgraphs from PPI network, which often represent functionally relevant protein complexes. 2 modules were retrieved from the PPI network constructed using co-expressed DEGs (Figs. 4B–4C). Among them, the module 1 included seven nodes (genes) and 11 edges (interactions), and the clustering score (density multiplied by the number of members) was 3.667; the module 2 included five nodes (genes) and seven edges (interactions), and the clustering score (density multiplied by the number of members) was 3.5. To rank the important genes within the co-expressed DEGs, the CytoHubba plug-in in Cytoscape was employed based on the degree centrality (Fig. 4E). The top five key genes, identified based on their node degree, were REN, NPHS2, SLC12A3, SLC12A1, and AQP1.
X2K construction and visualization of the upstream regulatory network
We used X2K to construct and visualize the upstream regulatory network of the co-expressed DEGs (Fig. 4D). We computationally predicted the involvement of upstream cell signaling pathways and identified the regulatory associations between TFs, protein kinases, and their target genes. E2F Transcription Factor 1 (E2F1) and CAMP Responsive Element Modulator (CREM) were the most important TFs that regulated the co-expressed DEGs. In addition, Mitogen-Activated Protein Kinase 14 (MAPK14) and cyclin-dependent kinase 4 (CDK4) were identified as the most important kinases controlling the co-expressed DEGs. Together, the prediction of the upstream regulatory network controlling the co-expressed DEGs could help us to conduct in-depth mechanism research.
GO enrichment analysis of the top five key genes
The functional annotations of top five key genes were performed by DAVID, GO analysis results revealed of BP, CC and MF with p value (Table 1).
Term | P value | Genes |
---|---|---|
Biological Process | ||
cell volume homeostasis | 6.72E−06 | SLC12A3, SLC12A1, AQP1 |
cellular response to inorganic substance | 8.26E−04 | SLC12A3, AQP1 |
chloride ion homeostasis | 0.00227132 | SLC12A3, SLC12A1 |
sodium ion homeostasis | 0.00350859 | SLC12A3, SLC12A1 |
glomerular filtration | 0.00392075 | NPHS2, AQP1 |
Cellular Component | ||
apical plasma membrane | 0.00196873 | SLC12A3, SLC12A1, AQP1 |
plasma membrane | 0.00450275 | SLC12A3, NPHS2, SLC12A1, REN, AQP1 |
extracellular exosome | 0.00459903 | SLC12A3, NPHS2, SLC12A1, AQP1 |
apical part of cell | 0.01410947 | REN, AQP1 |
membrane | 0.02068773 | SLC12A3, SLC12A1, REN, AQP1 |
Molecular Function | ||
sodium: potassium: chloride symporter activity | 6.34E−04 | SLC12A3, SLC12A1 |
cation: chloride symporter activity | 0.00126847 | SLC12A3, SLC12A1 |
potassium: chloride symporter activity | 0.00190225 | SLC12A3, SLC12A1 |
Validation of top five key genes expression
In the GEO dataset analysis, REN, NPHS2, SLC12A3, SLC12A1, AQP1 were significantly downregulated in WT tissues. To validate this finding, the expression levels of the top 5 key genes in WT Wit-49 cells and HK12 normal kidney cells, we performed RT-qPCR. The results revealed that the mRNA expression levels of top five key genes were all downregulated in the WT Wit-49 cells. No statistically significant relationship existed of REN and SLC12A1 (Fig. 5A).
To further investigate the expression levels of AQP1 in renal tubules and WT tissues. Western blotting showed that the expression of AQP1 protein in the WT Wit-49 cells was significantly lower than that in normal renal tubular epithelial HK2 cells (Fig. 5B). We used immunohistochemical (IHC) staining to detect the expression levels in normal renal tissues and in WT tissues. AQP1 was expressed in different parts of the tissues, showing a brown color, and was located in the cytoplasm and cell membrane. AQP1 was expressed in glomeruli, renal tubules, and cancerous tissues and was clearly stained in normal renal tissues. The AQP1 level in pathological sections was quantified by ImageJ software, and the average optical density (AOD) was obtained. The results showed that the normal renal tissues had a higher AOD value than the WT tissues. The protein levels of AQP1 in WT tissues, which were detected by IHC, also confirmed that the protein-level expression of AQP1 is lower in WT (Fig. 5C).
Overexpression of AQP1 suppresses the migration and invasion of WT cells in vitro
The functional evaluation of AQP1 in WT cells was performed using an overexpression plasmid, which resulted in a substantial increase in AQP1 expression in the AQP1 overexpression group (Fig. 6A). Wound healing and Transwell assays were conducted to investigate the impact of AQP1 on WT cell migration and invasiveness. The findings revealed that AQP1 overexpression significantly reduced the migratory and invasive capacity of Wit-49 cells (Fig. 6B). Notably, the scratch healing rate in the AQP1 overexpression group (32.90 ± 5.00)% was significantly lower than that in the negative control group (78.70 ± 4.70)% (t = 6.709, P < 0.01), indicating that AQP1 overexpression significantly inhibited the migration ability of WT cells. The results of Transwell assays showed that the number of perforated cells was significantly lower in the AQP1 overexpression group (179.00 ± 37.74) than in the negative control group (487.67 ± 41.72) (t = 5.486, P < 0.01), suggesting that AQP1 overexpression significantly inhibited the invasion capacity of WT cells. To investigate the potential impact of AQP1 overexpression on tumor metastasis, the influence of AQP1 on epithelial-mesenchymal transition (EMT) was assessed using Western blotting. The results demonstrated that the AQP1 overexpression group exhibited decreased levels of Vimentin and N-Cadherin, while the expression of E-Cadherin showed an opposite trend compared to the negative control group (Fig. 6A). Collectively, these findings suggest that AQP1 overexpression suppresses the migration, invasion, and EMT of WT cells.
The expression of F-actin in the negative control group increased significantly and metastasized to the pericellular periphery. Moreover, the cell volume increased, and lamellipodia, filopodia and stress fibers appeared. Together, F-actin expression was lower, and lamellipodia and filopodia formation decreased in the AQP1 overexpression group. By regulating the remodeling and dynamic changes of the cytoskeleton, cells were able to alter their shape, generate crawling pseudopods, and reorganize and rearrange microfilaments and microtubules, which could guide directional cell migration. The cell volume increased, and lamellipodia, filopodia, and stress fibers appeared, these changes collectively indicate an increase in cell migration capability. Overall, AQP1 overexpression decreased the formation of lamellipodia and filopodia, thereby inhibiting cell migration (Fig. 6C).
Discussion
WT is a prevalent solid tumor in pediatric patients, characterized by challenging early diagnosis. An urgent need exists to improve risk assessment and find a dependable biomarker for precise evaluation of WT patients. In this study, bioinformatics analysis of the gene chip data sets GSE57269, GSE73209 and GSE66405 was first performed by GEO2R. We identified 73 co-expressed DEGs. CytoHubba used PPI network to perform multidimensional analysis on co-expressed DEGs. We ranked co-expressed DEGs based on Degree and identified the top 5 key genes: REN, NPHS2, SLC12A3, SLC12A1, and AQP1.
It has been well documented that REN is expressed and plays important roles in WT. McKenzie et al. (1996) confirmed that WT consisted of a mixture of cells expressing the renin gene, including both tumor cells and perivascular stromal cells. Steege et al. (2008) demonstrated that the Wilms’ tumor protein WT1 participates in renin gene regulation. Mutations in the NPHS2 can disrupt the normal formation and operation of the kidney’s filtration system, leading to the onset of proteinuria and related symptomatic manifestations. The Wilms’ tumor suppressor 1 (WT1) mutations are thought to significantly contribute to the onset of Wilms’ tumor (Huff, 1998). The conditional deletion of WT1 specifically in podocytes (WT1fl/fl;Nphs2-Cre) resulted in WT1 expression being restricted to the capillary loop stage, while no presence was observed in mature glomeruli. The kidneys demonstrated a notable decline in mature glomeruli and proximal convoluted tubule count, indicating the critical role of WT1 in regulating podocyte maturation and maintaining proper renal filtration function. Furthermore, WT1 has been found to regulate the expression of Nphs2, a conserved target gene in podocytes (Dong et al., 2015). The proteins encoded by the genes SLC12A3, SLC12A1 and AQP1 are all transmembrane transport proteins. Their main function is to facilitate the transportation of various substrates across biological membranes. SLC12A3 and SLC12A1 are two different members of the solute carrier family 12 gene family. Experimental investigations into the renal salt transport molecules SLC12A3 and SLC12A1 have revealed that a significant portion of the identified mutations lead to impaired transport functionality. These mutations disrupt transport by affecting various aspects, including biosynthetic processing, trafficking, ion transport, and regulation. SLC12A1 mutation can lead to Bartter syndrome, while SLC12A3 mutation primarily result in Gitelman syndrome (Welling, 2014).
AQP1, the first aquaporin identified and extensively studied in the AQP family (Denker et al., 1988), has been detected in various types of human malignancies (Chen et al., 2006; Saadoun et al., 2002; Vacca et al., 2001). In Renal Cell Carcinoma (RCC), AQP1 expression is generally low (Ticozzi-Valerio et al., 2007), and its association with overall survival (OS) has been well-established. Among the key genes identified through bioinformatics analysis, AQP1 has been validated as an important biomarker for RCC (Morrissey et al., 2015). Furthermore, AQP1 has been identified as an autonomous prognostic factor and a prognostic-related factor in clear cell renal cell carcinoma (ccRCC) (Li et al., 2022; Wang et al., 2022). Yet, the expression and functional implications of AQP1 in WT are not well understood. Our research further verified the expression of AQP1 in WT and its effect on cell migration in WT cells. We confirmed AQP1 expression at both the mRNA and protein levels. Our findings indicated that elevated levels of AQP1 exert inhibitory effects on the migratory and invasive capacities of Wilms’ tumor cells, and the above effects may be related to affecting the cytoskeletal microfilament structure.
The involvement of AQP1 in cancer migration and invasion is of great significance, as these processes play pivotal roles in human carcinogenesis. It is noteworthy that AQP1 has demonstrated divergent effects on migration in different types of cancer (Moon, Moon & Kang, 2022). Studies have indicated that AQP1 overexpression in B16F10 melanoma cells and 4T1 mammary gland tumor cells promotes cell migration and lamellipodia formation by enhancing osmotic water permeability across the cell membrane (Hu & Verkman, 2006; McLean et al., 2005). Furthermore, Jiang et al. conducted a study to examine the expression of AQP1 in diverse cancer cell lines, including an HT20 colon cancer cell model, revealing that the introduction of AQP1 through adenovirus-mediated expression elevated the water permeability of cellular membranes (Jiang, 2009). Conversely, down-regulation of AQP1 has been associated with the protection of tumors against cytotoxic edema by maintaining extracellular acidification, thereby facilitating the metastasis of glioma (Pedersen, Hoffmann & Mills, 2001). However, Aishima et al. found that a significant association exists between low or negative expression of AQP1 and certain unfavorable characteristics in intrahepatic cholangiocarcinoma, including larger tumor size and poorly differentiated histology. Additionally, a significant association was identified between decreased AQP1 expression and the presence of lymph node metastasis. Interestingly, a reciprocal association was observed between AQP1 expression and MUC5AC, a mucus core protein, and their distributions showed a complementary pattern. The downregulation of AQP1 appeared to be closely linked to the expression of MUC5AC and the aggressive behavior of the tumor (Aishima et al., 2007). According to recent research, the expression of AQP1 had been detected in biliary tract carcinoma (BTC), and its levels decreased as the carcinoma progresses in terms of invasion. These results suggested that AQP1 expression held great potential as a valuable prognostic marker and indicator of tumor invasion in BTC (Sekine et al., 2016). However, how AQP1 affects WT migration is particularly important. EMT activation plays a crucial role in the metastasis of cancer cells, as it facilitates the transition of epithelial cells into a mesenchymal phenotype. Notably, attenuation of EMT triggers cytoskeletal rearrangement, further modulating cellular behavior. We examined the effect of AQP1 overexpression on EMT in WT. We detected that the expression of biomarkers of EMT were reduced in WT. Current studies are focused on the process of cell migration, including the extension of plasma membrane protrusions or lamellipodia and filopodia at the “leading edge”, the formation of new adhesion points at the front end of the cell, the contraction of the cell body, and the deadhesion of the cell tail. Among these cell migration processes, plasma membrane protrusion at the “leading edge” or the extension of lamellipodia and filopodia are the main driving forces (Webb, Parsons & Horwitz, 2002). The cytoskeleton plays a vital role in cell migration (Seetharaman & Etienne-Manneville, 2020). To visualize microfilament structures, Phalloidin-iFlour 488 was employed in the labeling of cells in each experimental group. Notably, the AQP1 overexpression group exhibited significant changes in cytoskeletal microfilament organization. This suggests that overexpression of AQP1 inhibited the migration of WT cells, possibly by affecting the cell microfilament structure and interfering with lamellipodia and filopodia formation. This study revealed that overexpression of AQP1 inhibited WT cell migration and invasion, which might be related to interference with the formation of the cytoskeleton.
New research findings have illuminated the dynamic process of kidney development, specifically highlighting the transformation of cells from the cap mesenchyme, a unique progenitor state exclusive to the kidney, into an epithelial phenotype termed mesenchymal-to-epithelial transition (MET). Subsequently, these cells undergo differentiation into diverse epithelial cell types, playing a pivotal role in the development of tubular structures within the nephron. Disruptions in the critical transition process have been implicated in the pathogenesis of WT. In this particular study, early, middle, and late embryonic kidney samples, as well as WT samples, were subjected to sequencing analysis. The findings exhibited a sequential decline in mesenchymal-associated gene expression and a simultaneous increase in epithelial-associated gene expression during fetal kidney development. In contrast, the WT samples exhibited elevated expression levels of mesenchymal-associated genes and relatively reduced expression levels of epithelial-associated genes (Wineberg et al., 2022). We postulate that the low expression levels of AQP1 in WT may inhibited the process of MET, while the overexpression of AQP1 may potentially reduce the formation of mesenchymal in cells.
In conclusion, We identified co-expressed DEGs with three datasets GSE57269, GSE73209 and GSE66405 for WT, and predicted PPI networks, GO terms, KEGG pathways for co-expressed DEGs. The top five key genes were identified: REN, NPHS2, SLC12A3, SLC12A1, and AQP1. The overexpression of AQP1 might inhibit WT cell migration and invasion, which could result from decreased EMT and dysregulated cytoskeleton formation. These findings offer valuable insights into the molecular mechanisms contributing to the onset and advancement of WT.
Supplemental Information
GSE66405 DEGs Gene ID matching gene sympol p > 0.05, |logFc| 1.5
GO enrichment analysis and pathway analysis of co-expressed DEGs
Relative mRNA expression levels of REN, NPHS2, SLC12A3, SLC12A1, and AQP
Values are 2−ΔΔ Ct.
Wound healing assays of the negative control group and the AQP1 overexpression group of WT Wit-49 cells
Transwell assays of the negative control group and the AQP1 overexpression group of WT Wit-49 cells
Cytoskeletal assays showed lamellipodia of the negative control group and the AQP1 overexpression group of WT Wit-49 cells
The expression of protein of AQP1 in normal renal tubular epithelial HK2 cells and WT Wit-49 cells; Western blot of the upregulation efficiency of overexpression of AQP1 in WT Wit-49 cells; The expression of protein of Vimentin, E-Cadherin and N-Cadherin
The expression of AQP1 in WT tissues and normal renal tissues
The magnification was 100.
The expression of AQP1 in WT tissues and normal renal tissues
The magnification was 200.